Fosamax Benefits Bones in Young CF Patients (Medpage Today, 1 June 2013)

03 Jun 2013


An Italian study published in The Lancet Respiratory Medicine assesses bone quality by age group in cystic fibrosis patients given alendronate.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story